Skyline Dx – Amsterdam Academic Ventures

Our portfolio

Skyline Dx

Skyline Dx is a molecular diagnostics company focusing on oncology and infectious diseases. Their platform-agnostic tests range from PCR to Next Generation Sequencing technologies. Skyline Dx partners with discovery and commercial companies to develop and distribute their diagnostic tests. The company is dedicated to advancing precision medicine through innovative molecular diagnostics.

Industry: Diagnostics, Oncology

Want to get in contact about Skyline Dx?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

Upcycling phosphate waste into sustainable industrial products.

Providing advanced defect detection for carbon composites in aerospace and wind energy.

Specializing in AI-powered audience intelligence, Sightcorp provides automated facial analysis and emotion recognition technology.

Transforming content into audio-based e-learning for on-the-go learning.

Upcycling phosphate waste into sustainable industrial products.

Providing advanced defect detection for carbon composites in aerospace and wind energy.

Specializing in AI-powered audience intelligence, Sightcorp provides automated facial analysis and emotion recognition technology.

Transforming content into audio-based e-learning for on-the-go learning.

Our portfolio

Want to get in contact about Skyline Dx?

Marc Roelofs

Our portfolio

Holdings of our founding institutes

Contact